Sign in
Explore the registryTrack Sacituzumab govitecan-hziy's trials

EVOKE-01

Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Sacituzumab Govitecan-hziy (SG)OngoingActive not recruitingPhase 3Open NCT05089734 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…